|
Alprostadil Cream treatment for female sexual arousal disorder to be presented.
Publication: Pharma Business Week Publication Date: 20-SEP-04 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2004 NewsRX
2004 SEP 20 - (NewsRx.com & NewsRx.net) -- NexMed, Inc., (NASDAQ:NEXM) announced that it will present the new findings of a pilot clinical study conducted offshore, entitled "A Pilot Clinical Study of a Topical Alprostadil Cream for the Treatment of Female Sexual Arousal Disorder (FSAD)."
The presentation will take place...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Pharma Business Week |
E.U. patent covers autologous dermal fibroblasts for skin, soft tissue...
September 20, 2004
|
Progress reported in smallpox vaccine development.
September 20, 2004
|
SIGA announces receipt of $12 million in NIH funding for biodefense.
September 20, 2004
|
Pharma company files FDA IND for Provectus, treatment of solid tumors.
September 20, 2004
|
Intensive training in elite gymnasts slows bone development, two studi...
September 20, 2004
|
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
